Vimarsana
Biggest News Aggregation in the World

Robert Mikos News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Robert Mikos. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Robert Mikos Today - Breaking & Trending Today

Louisiana may reclassify drugs used in abortion as controlled dangerous substances - Vimarsana News

Louisiana may reclassify drugs used in abortion as controlled dangerous substances

Louisiana could be the first state to regulate mifepristone and misoprostol in the same way as some narcotics and stimulants. Opponents predict harmful delays in miscarriage and other lawful uses.

Source: kpbs.org
Louisiana may reclassify drugs used in abortion as controlled dangerous substances - Vimarsana News

Louisiana may reclassify drugs used in abortion as controlled dangerous substances

Louisiana could be the first state to regulate mifepristone and misoprostol in the same way as some narcotics and stimulants. Opponents predict harmful delays in miscarriage and other lawful uses.

Source: wjct.org
In Louisiana, drugs for medication abortion could become controlled substances : Shots - Vimarsana News

In Louisiana, drugs for medication abortion could become controlled substances : Shots

Louisiana could be the first state to regulate mifepristone and misoprostol in the same way as some narcotics and stimulants. Opponents predict harmful delays in miscarriage and other lawful uses.

Source: npr.org
The DEA Plans to Reschedule Marijuana: What Happens Next? - Vimarsana News

The DEA Plans to Reschedule Marijuana: What Happens Next?

The DEA's plan to reschedule marijuana from a Schedule I controlled substance to Schedule III was expected. But what does it mean for clinicians and patients?

Easing Marijuana Laws Doesn't Mean the Drug Is Safer - Vimarsana News

Easing Marijuana Laws Doesn't Mean the Drug Is Safer

You shouldn’t draw major conclusions about the safety of marijuana amid the recent announcement that federal regulators may reclassify the drug, experts are cautioning.

Source: webmd.com